The management of multiple myeloma in 2021 Claudio Cerchione, MD, PhD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, gives an overview of the treatment landscape for multiple myeloma, highlighting recent advances in frontline therapy, including the introduction of daratumumab-based approaches in both transplant-eligible and transplant-ineligible patients. Dr […]

Read More